ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Bone Loss in Women with Anorexia Nervosa

This study is currently recruiting patients.

Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

Women with Anorexia Nervosa have been found to have low bone density. The study will determine whether administration of low doses of a natural hormone, testosterone and/or risedronate, a medication to help prevent bone breakdown will improve or prevent bone loss in this condition.

Condition Treatment or Intervention
Anorexia Nervosa
  Drug: Testosterone
 Drug: Risedronate

MedlinePlus related topics:  Eating Disorders

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study

Official Title: IGF-1 and Bone Loss in Women Anorexia Nervosa

Further Study Details: 

Expected Total Enrollment:  80

Study start: June 2003

Eligibility

Ages Eligible for Study:  18 Years   -   45 Years,  Genders Eligible for Study:  Female

Criteria

Inclusion Criteria:

Exclusion Criteria:


Location and Contact Information

Anne Klibanski, M.D.      617-726-3870 
Jennifer L Minihan, P.A.      617-724-7393    jminihan@partners.org

Massachusetts
      Massachusetts General Hospital, Boston,  Massachusetts,  02114,  United States; Recruiting
Anne Klibanski, M.D.,  Principal Investigator
Karen K Miller, M.D.,  Sub-Investigator

More Information

Study ID Numbers:  5 R01 DK052625-07
Record last reviewed:  August 2004
Record first received:  August 16, 2004
ClinicalTrials.gov Identifier:  NCT00089843
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-11-08
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act